Literature DB >> 22886194

Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States.

Veerajalandhar Allareddy1, Sankeerth Rampa, Veerasathpurush Allareddy.   

Abstract

BACKGROUND: This study examines hospital charges and length of stay (LOS) associated with septicemia during hospitalization for leukemia treatment among children aged ≤18 years.
METHODS: Nationwide Inpatient Sample (year 2008) was used. All hospitalizations (regardless of their discharge status following hospitalization) among children aged ≤18 years with a primary diagnosis of leukemia were selected. Leukemia was identified using ICD-9-CM codes in the primary diagnosis field. The presence of septicemia during hospitalization was identified using ICD-9-CM codes in the secondary diagnosis field. Multivariable linear regression analyses were made to examine the effect of septicemia on hospitalization charges and LOS.
RESULTS: Totally 6220 hospitalizations were attributed to leukemia treatment. Among these, 787 had septicemia. The mean hospitalization charge for those with septicemia was $279,137 and for those without septicemia was $113,530. The average LOS for those with septicemia was 33.18 days while the LOS for those without septicemia was 13.79 days. Septicemia was associated with increased hospitalization charges and a prolonged duration of stay in hospital after adjustments for confounders (P<0.0001).
CONCLUSIONS: Septicemia is associated with adverse outcomes among children hospitalized for leukemia treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22886194     DOI: 10.1007/s12519-012-0361-5

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  16 in total

1.  'Sepsis' and multi-organ failure: predictors of poor outcome after hematopoietic stem cell transplantation in children.

Authors:  H Bönig; D T Schneider; I Sprock; P Lemburg; U Göbel; W Nürnberger
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

4.  The prognosis of oncologic patients in the pediatric intensive care unit.

Authors:  A van Veen; A Karstens; A C van der Hoek; D Tibboel; K Hählen; E van der Voort
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

5.  Predictors of outcome in the pediatric intensive care units of children with malignancies.

Authors:  Ron Ben Abraham; Amos Toren; Nava Ono; Avi A Weinbroum; Amir Vardi; Zohar Barzilay; Gideon Paret
Journal:  J Pediatr Hematol Oncol       Date:  2002-01       Impact factor: 1.289

6.  Oncologic emergencies II. Hematologic and infectious complications of cancer and cancer treatment.

Authors:  G J Allegretta; S J Weisman; A J Altman
Journal:  Pediatr Clin North Am       Date:  1985-06       Impact factor: 3.278

7.  The epidemiology of severe sepsis in children in the United States.

Authors:  R Scott Watson; Joseph A Carcillo; Walter T Linde-Zwirble; Gilles Clermont; Jeffrey Lidicker; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

Review 8.  Childhood acute lymphoblastic leukaemia--current status and future perspectives.

Authors:  C H Pui; D Campana; W E Evans
Journal:  Lancet Oncol       Date:  2001-10       Impact factor: 41.316

Review 9.  Progress and controversies in the treatment of pediatric acute myelogenous leukemia.

Authors:  Robert J Arceci
Journal:  Curr Opin Hematol       Date:  2002-07       Impact factor: 3.284

Review 10.  Pediatric cancer patients in clinical trials of sepsis: factors that predispose to sepsis and stratify outcome.

Authors:  Robert Tamburro
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

View more
  2 in total

1.  Financial Burden of Pediatric Cancer for Patients and Their Families.

Authors:  Echo L Warner; Anne C Kirchhoff; Gina E Nam; Mark Fluchel
Journal:  J Oncol Pract       Date:  2014-10-14       Impact factor: 3.840

2.  Septicemia after chemotherapy for childhood acute lymphoblastic leukemia in China: A multicenter study CCCG-ALL-2015.

Authors:  Yiping Zhu; Rong Yang; Jiaoyang Cai; Jie Yu; Yanjing Tang; Yumei Chen; Ningling Wang; Hailong He; Xuedong Wu; Frankie W T Cheng; Lirong Sun; Yingyi He; Xiuli Ju; Xin Tian; Qun Hu; Runming Jin; Kaili Pan; Yongjun Fang; Xiaowen Zhai; Hui Jiang; Chi-Kong Li
Journal:  Cancer Med       Date:  2020-01-28       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.